AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyObservationalPublished in a peer-reviewed journal
Cholesterol Metabolism and Disability in Severe Progressive MS Patients
A study involving 53 severe progressive multiple sclerosis (MS) patients and matched controls revealed that lower levels of HDL-C, ApoA-I, and ApoA-II, along with higher levels of ApoB and ApoE, were significantly associated with increased disability as measured by the EDSS and CombiWISE scales.
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
These findings suggest a strong link between lipid metabolism and disability in severe progressive MS, highlighting potential areas for further research and insights into disease progression.
What this does not prove
The study does not establish direct causation, only associations, and the relatively small sample size may limit the general applicability of the results.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- 106 · 53 Severe progressive MS patients and 53 matched controls
- Randomised
- No
- Controlled
- Yes
- Primary endpoint met
- Yes
- Relevant MS type
- SPMS
- Publication date
- 2026-10-15
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Neuroinflammation, Other
Original sources
- Primary evidenceDysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis. ↗DOI: 10.1002/acn3.70550
Supporting passages (17)
study phaseThe goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS.
study designMETHODS: The study sample comprised 53 Severe PMS patients (Expanded Disability Status Scale, EDSS score: 7.0-9.5) requiring skilled nursing and 53 age, sex- and disease duration-matched community-dwelling Control PMS patients (EDSS score: 3.0-6.5).
subjectsMETHODS: The study sample comprised 53 Severe PMS patients (Expanded Disability Status Scale, EDSS score: 7.0-9.5) requiring skilled nursing and 53 age, sex- and disease duration-matched community-dwelling Control PMS patients (EDSS score: 3.0-6.5).
speciesMETHODS: The study sample comprised 53 Severe PMS patients (Expanded Disability Status Scale, EDSS score: 7.0-9.5) requiring skilled nursing and 53 age, sex- and disease duration-matched community-dwelling Control PMS patients (EDSS score: 3.0-6.5).
sample sizeMETHODS: The study sample comprised 53 Severe PMS patients (Expanded Disability Status Scale, EDSS score: 7.0-9.5) requiring skilled nursing and 53 age, sex- and disease duration-matched community-dwelling Control PMS patients (EDSS score: 3.0-6.5).
sample size basisMETHODS: The study sample comprised 53 Severe PMS patients (Expanded Disability Status Scale, EDSS score: 7.0-9.5) requiring skilled nursing and 53 age, sex- and disease duration-matched community-dwelling Control PMS patients (EDSS score: 3.0-6.5).
randomizedMETHODS: The study sample comprised 53 Severe PMS patients (Expanded Disability Status Scale, EDSS score: 7.0-9.5) requiring skilled nursing and 53 age, sex- and disease duration-matched community-dwelling Control PMS patients (EDSS score: 3.0-6.5).
controlledPatients underwent neurological examinations and provided blood samples.
peer reviewedJournal: Annals of clinical and translational neurology
primary endpoint metTotal cholesterol, ApoA-II, and ApoB were associated with disability on the EDSS and CombiWISE scale.
research categoriesDysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS).
relevant ms typesThe goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS.
publication datePublication date: 2026-10-15
comparatorCholesterol and apolipoprotein (Apo) profiles, nuclear magnetic resonance spectroscopy metabolomic profiles, inflammatory cytokines, neuroaxonal, and glial injury biomarkers were obtained.
primary endpointDisability was measured on the EDSS and the Combinatorial Weight-Adjusted Disability (CombiWISE) scales.
findingsDisrupted cholesterol metabolism and chronic inflammation are strongly linked to greater disability in Severe PMS.
limitationsTitle: Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.